
Opinion|Videos|March 4, 2024
An Overview of the SPOTLIGHT Trial for PSMA PET in Prostate Cancer
A panel of experts introduce the SPOTLIGHT study, evaluating PSMA PET in patients with prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Enzalutamide plus talazoparib demonstrates clinical activity in mHSPC
4
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
5














